FAP and neoplasm: Recently, 68Ga-labeled quinoline-based FAP inhibitor (FAPI) has allowed for the imaging of tumor stroma by targeting FAP, among which [68Ga]FAPI-04 has exhibited favorable tumor-to-background ratio (TBR) and kinetics [7, 8].